Today’s Market Snapshot U.S. stocks drifted yesterday as bullish AI chatter clashed with mixed signals from cyclical earnings, leaving major indexes pinned near the flatline.
Introduction Cybin Inc., doing business as Helus Pharma, is a clinical-stage biopharmaceutical company focused on novel psychedelic-based therapeutics for mental health (www.otcmarkets.com). In January 2026
Opening Recap Market Pulse: Equities drifted higher yesterday despite the Fed’s tame commentary, with tech wobbling on Tesla’s earnings jitters while broader sectors held firm.
